Job posting has expired
Rare Communications Manager
Chiesi | |
United States, Massachusetts, Boston | |
One Boston Place, Suite 4000 (Show on map) | |
May 24, 2025 | |
|
About us Based in Parma, Italy, Chiesi is an international research-focused pharmaceuticals and healthcare group with over 85 years' experience, operating in 30 countries with more than 6,000 employees (Chiesi Group). To achieve its mission of improving people's quality of life by acting responsibly towards society and the environment, the Group research, develops and markets innovative drugs in its three therapeutic areas: AIR (products and services that promote respiration, from new-born to adult populations), RARE (treatment for patients with rare and ultra-rare diseases) and CARE (products and services that support special care and consumer-facing self-care). Chiesi USA Chiesi USA is a specialty pharmaceutical company focused on developing and promoting products for the hospital, adjacent specialty and rare disease markets. We are a B Corp and Benefit company awarded Top Employer status for six consecutive years and certified as a Great Place to Work. What we offer Chiesi offers competitive benefits, services, and programs that enrich the personal and professional lives of our employees. Our shared values of passion, innovation, trust and integrity bring out the individual talents and diverse perspectives of each of our colleagues. Our environment encourages each individual to reach his or her full potential and drive outstanding results. We celebrate that "Every one of us is different. Every one of us is Chiesi." Who we are looking for Purpose
The Rare Communications Business Partner will navigate a company in full evolution, supporting the Rare business unit, in a fully international context, supporting them in communicating their identity and their evolution. This role is instrumental in shaping Chiesi's global reputation and driving impactful communication strategies in rare diseases. Main Responsibilities
We are looking for an experienced and dynamic Global Communications Business Partner to support our Rare Diseases portfolio, providing expertise and strategic communication across markets. With a minimum of five years in healthcare communications-whether from a PR agency or within the pharmaceutical industry-you'll be a key contact for our global brand leaders, contributing insights, creativity, and strategic thinking for media and PR activities. You will also serve as the communications point of contact for internal initiatives in Boston, working closely with our Patient Advocacy, Public Affairs, and Chiesi USA teams to ensure consistent messaging and alignment. 1. Strategic Communications & PR Support: 2. Internal Communications: 3. Patient Advocacy and Public Affairs Collaboration: 4. Stakeholder Engagement: Experience Required
At least 5 years of experience in the field of Healthcare Communication (with focus on external communication / therapeutical area communication) in multinational companies or PR agencies. Experience in Rare Diseases space is a plus. Technical Skills
* Strong strategic thinking and creative problem-solving abilities, with a proven track record in media relations and public relations within the healthcare industry. Soft Skills
* Proven ability to work cross-functionally. Education
Degree in Communications or in Social or Political Sciences, Economics (or others) with a specialization in Communications Languages
English native speaker, Italian will be considered a plus. Chiesi USA is an equal opportunity employer committed to hiring a diverse work force at all levels of our business. All qualified applicants receive consideration for employment without regard to race, national origin, age, sex, religion, disability, sexual orientation, marital status, veteran status, gender identity or expression or any other basis protected by local, state or federal law. This policy applies with regard to all aspects of one's employment, including hiring, transfer, promotion, compensation, eligibility for benefits and termination. | |
May 24, 2025